GMED INVESTOR ALERT: Investigation of Globus Medical, Inc. Announced by The Law Offices of Howard G. Smith

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE:GMED) concerning the Company’s and its officers’ possible violations of federal securities laws.

On April 22, 2015, the Company announced that its auditors, KPMG LLP, had declined to stand for reelection as auditor of the Company’s financial statements. The Company stated in relevant part, “[o]n April 16, 2015, KPMG LLP ("KPMG") orally notified Globus Medical, Inc. (the "Company") that upon the completion of KPMG's review of the Company's consolidated financial statements for the quarterly reporting period ended March 31, 2015 and the filing of the related Quarterly Report on Form 10-Q, KPMG declines to stand for reelection as the independent registered public accounting firm for the Company. KPMG's decision was accepted by the audit committee of the Company's board of directors.” On this news, shares of Globus fell on April 23, 2015, as much as $1.33 per share during intraday trading, on unusually high volume.

If you purchased shares of Globus prior to April 23, 2015, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020; by telephone at 215-638-4847, toll-free at 888-638-4847; or by email to howardsmith@howardsmithlaw.com; or visit our website at http://www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Law Offices of Howard G. SmithHoward G. Smith, Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com

Globus Medical (NYSE:GMED)
Historical Stock Chart
From Mar 2024 to Apr 2024